NSABP Foundation   Report issue

Foundation Phase 1 Phase 2 Phase 3
Founded: Pittsburgh PA United States (1957)

Organization Overview

First Clinical Trial
1977
NCT00427570
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

NSABP Foundation Inc